Clinical Trial Update: Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravitreal bevacizumab for choroidal neovascularization associated with angioid streaks was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioid Streaks
• Choroidal Neovascularization

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Angioid Streaks, Choroidal Neovascularization | Phase 3 | Status: TERMINATED